NCT06748963Recruiting
Fasted Exercise Training in Type 1 Diabetes (FED-T1D)
Exercise Training Before (Fasted) Versus After (Fed) Breakfast in Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
This study compares aerobic exercise training performed before breakfast (i.e., in the fasted state) to similar training performed after breakfast in people with type 1 diabetes. Training will take place over 12 weeks.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 13 Nov 2024
- Start date
- 1 Jan 2025
- Primary completion date
- Apr 2027
- Lead sponsor
- University of Alberta
- Diseases
- Type 1 diabetes
- NCT number
- NCT06748963
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 1 Jan 2025 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Major complication within the previous 3 months (e.g., severe hypoglycemia requiring assistance, diabetic ketoacidosis, or cardiovascular event).
- Use of an injection-based insulin therapy (ex. multiple daily injections or combined pump and injection-based delivery).
Other illness
- Restriction in aerobic or resistance exercise due to significant diabetes complications (e.g., severe peripheral neuropathy, active proliferative retinopathy, etc.) or other type of limitations (e.g., orthopedic, severe arthritis, etc.).
- Uncontrolled hypertension (e.g., blood pressure \>160 mmHg systolic or \>100 mmHg diastolic).
- Implanted device, material, or having a condition contraindicated to MRI.
Other
- Ongoing pregnancy or breastfeeding.
- Inability to give consent.
Who the study is looking for
- Clinical diagnosis of type 1 diabetes for 5 or more years.
- Treatment using an insulin pump with no change in treatment modality for \> 2 continuous months and willing to share CGM data with the research team. Insulin delivery can be managed using either manual open-loop system (non-AID) or a hybrid closed loop (AID) systems.
- Using rapid (e.g., Aspart, Lispro or Glulisine) or ultra-rapid (e.g., FiAsp) acting insulin analogs.
- HbA1c 7.0-9.9%.
- Have BMI of 25 kg/m2 or above
- Have waist circumference associated with central obesity/metabolic syndrome as per Diabetes Canada definition
- 94cm for males of European, Sub-Saharan African, Eastern Mediterranean and Middle Eastern descent
- 90cm for males of South Asian, Chinese, Japanese, South and Central American descent
- 80cm for females
- No history of stroke, myocardial infarction, or coronary artery disease
- Not wearing implantable device such as a pacemaker, neurostimulators, aneurysm clips, metal fragments, epicardial electrodes, cochlear implants, magnetic ocular implants, penile implants, magnetic tissue expander, some types of breast implants, magnetic orthopedic implants, magnetic dental implants, hearing Aids, intravascular implants, for example VCI filters, coils, stents, cardiac septum implants, ventricular bypass devices.
- Use a CGM in routine diabetes management.
Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alberta Coordinator of this site? Confirm its status | Edmonton | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.